Strata Critical Medical (SRTA) Depreciation & Amortization (CF) (2021 - 2026)

Strata Critical Medical (SRTA) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $3.1 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 80.32% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (up 57.43% YoY) and the FY2025 annual result came in at $8.2 million, up 37.29% from the prior year.
• Depreciation & Amortization (CF) climbed to $3.1 million in Q1 2026 per SRTA's latest filing, from $3.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $3.1 million in Q1 2026 and bottomed at $1.1 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $1.7 million (2025), against an average of $1.9 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) jumped 808.73%; it then plunged 30.6% in 2024.
• Tracing SRTA's Depreciation & Amortization (CF) over 5 years: stood at $2.3 million in 2022, then fell by 21.48% to $1.8 million in 2023, then dropped by 15.28% to $1.5 million in 2024, then jumped by 96.6% to $3.0 million in 2025, then advanced by 1.73% to $3.1 million in 2026.
• Per Business Quant, the three latest SRTA Depreciation & Amortization (CF) figures stand at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $1.7 million (Q3 2025).

Peer Comparison